{"disease":{"id":"gigantism","name":"gigantism"},"drugs":{"marketed":[{"drug_id":"lanreotide","indication_name":"Hypersomatotropic gigantism","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Somatuline Depot","generic_name":"LANREOTIDE","company_name":"Ipsen Pharma","drug_phase":"marketed","molecular_target":"Somatostatin receptor type 2","drug_class":"Somatostatin Analog","quality_score":10,"revenue":"1200","mechanism":"Somatuline Depot works by mimicking the natural hormone somatostatin to block the production of excess growth hormone."}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT00461188","title":"Genetics of Endocrine Tumours - Familial Isolated Pituitary Adenoma - FIPA","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Barts & The London NHS Trust","has_results":false},{"nct_id":"NCT00001595","title":"An Investigation of Pituitary Tumors and Related Hypothalmic Disorders","phase":"","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","has_results":false},{"nct_id":"NCT06523582","title":"Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients","phase":"","overall_status":"RECRUITING","enrollment_count":750,"lead_sponsor_name":"Universidad Nacional Autonoma de Mexico","has_results":false},{"nct_id":"NCT01673646","title":"Efficacy and Safety of Pasireotide LAR (Long-acting Release) in Japanese Patients With Acromegaly or Pituitary Gigantism","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":33,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}